250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies.
暂无分享,去创建一个
M. McDevitt | C. O'keefe | L. Gondek | J. Maciejewski | M. Sekeres | H. Makishima | H. Szpurka | A. Dunbar | Manjot Rataul | X. F. Wang
[1] G. Mufti,et al. Whole genome scanning as a cytogenetic tool in hematologic malignancies. , 2008, Blood.
[2] J. Maciejewski,et al. Phospho-STAT5 expression pattern with the MPL W515L mutation is similar to that seen in chronic myeloproliferative disorders with JAK2 V617F. , 2008, Human pathology.
[3] C. Preudhomme,et al. Cooperating gene mutations in acute myeloid leukemia: a review of the literature , 2008, Leukemia.
[4] C. O'keefe,et al. Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML. , 2008, Blood.
[5] M. McDevitt,et al. SNP Array Karyotyping Allows for the Detection of Uniparental Disomy and Cryptic Chromosomal Abnormalities in MDS/MPD-U and MPD , 2007, PloS one.
[6] L. Rönnstrand,et al. Grb2 mediates negative regulation of stem cell factor receptor/c-Kit signaling by recruitment of Cbl. , 2007, Experimental cell research.
[7] G. Mufti,et al. Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes. , 2007, Blood.
[8] Bas J. Wouters,et al. Segmental uniparental disomy as a recurrent mechanism for homozygous CEBPA mutations in acute myeloid leukemia , 2007, Leukemia.
[9] J. Downing,et al. Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11 , 2007, Oncogene.
[10] M. Caligiuri,et al. Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia. , 2007, Blood.
[11] Chunaram Choudhary,et al. Flt3-dependent transformation by inactivating c-Cbl mutations in AML. , 2007, Blood.
[12] Motohiro Kato,et al. Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays. , 2007, American journal of human genetics.
[13] A. Tsygankov,et al. The Cbl family proteins: Ring leaders in regulation of cell signaling , 2006, Journal of cellular physiology.
[14] Johan Eide,et al. Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.
[15] Jason C. Ting,et al. Analysis and visualization of chromosomal abnormalities in SNP data with SNPscan , 2006, BMC Bioinformatics.
[16] S. Akiki,et al. Acquired Isodisomy for chromosome 13 is common in AML, and associated with FLT3-itd mutations , 2005, Leukemia.
[17] Gudmundur A. Thorisson,et al. The International HapMap Project Web site. , 2005, Genome research.
[18] T. A. Lister,et al. Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias. , 2005, Cancer research.
[19] Shigeru Chiba,et al. A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. , 2005, Cancer research.
[20] Mario Cazzola,et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. , 2005, The New England journal of medicine.
[21] Sandra A. Moore,et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. , 2005, Cancer cell.
[22] P. Campbell,et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders , 2005, The Lancet.
[23] 松山 智洋. What's going on 造血器腫瘍 A gain-of-function mutation of JAK2 in myeloproliferative disorders. Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC. N Engl J Med. 2005; 352: 1779-90. PMID:15858187.--慢性骨髄増殖性疾患においてJAK2遺伝子の変異が高頻度にみられることを示した論文 , 2005 .
[24] Jan Bressler,et al. Epigenetics and human disease. , 2004, Annual review of genomics and human genetics.
[25] M. Lohuizen,et al. Stem Cells and Cancer The Polycomb Connection , 2004, Cell.
[26] P. Kosarev,et al. Evaluation and classification of RING-finger domains encoded by the Arabidopsis genome , 2002, Genome Biology.
[27] R. Kralovics,et al. Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera. , 2002, Experimental hematology.
[28] M. Caligiuri,et al. Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. , 2001, Cancer research.
[29] I. Day,et al. An efficient procedure for genotyping single nucleotide polymorphisms. , 2001, Nucleic acids research.
[30] F. Walker,et al. RING finger mutations that abolish c-Cbl-directed polyubiquitination and downregulation of the EGF receptor are insufficient for cell transformation. , 2001, Molecular cell.
[31] Ping Wang,et al. Structure of a c-Cbl–UbcH7 Complex RING Domain Function in Ubiquitin-Protein Ligases , 2000, Cell.
[32] W P Robinson,et al. Mechanisms leading to uniparental disomy and their clinical consequences , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.
[33] T. Hunter,et al. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. , 1999, Science.
[34] D. Bowtell,et al. The Cbl protooncoprotein stimulates CSF‐1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation , 1999, The EMBO journal.
[35] Z. Kam,et al. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. , 1998, Genes & development.
[36] L. Moretta,et al. Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses. , 1998, Immunology today.
[37] W. Langdon,et al. Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl , 1997, Oncogene.
[38] H. Band,et al. Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity , 1997, Molecular and cellular biology.
[39] J. Ferrara,et al. The Immunopathophysiology of Acute Graft‐Versus‐Host‐Disease , 1996, Stem cells.
[40] H. Kaneko,et al. TP53 mutations emerge at early phase of myelodysplastic syndrome and are associated with complex chromosomal abnormalities. , 1995, Blood.
[41] W. Langdon,et al. Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene. , 1994, The EMBO journal.
[42] H. Gralnick,et al. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia: Proposals by the French ‐ American ‐ British Cooperative Leukaemia Group , 1994, British journal of haematology.